Sensus Healthcare is a medical device company focused on providing treatments for both oncological and non-oncological skin conditions. Co. uses a proprietary low-energy X-ray technology known as superficial radiation therapy (SRT) and has incorporated SRT into a portfolio of treatment devices: the SRT-100, which is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; SRT-100+, which provides the same features as the SRT-100, with the addition of remote diagnostics; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application. The SRTS average annual return since 2016 is shown above.
The Average Annual Return on the SRTS average annual return since 2016 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether SRTS average annual return since 2016 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the SRTS average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|